人 IGLC2 抗体对
01AB00272
Immunoglobulin lambda constant 2 (IGLC2) plays a crucial role in the immune response by enabling antigen binding and receptor interaction. This protein is primarily expressed by B lymphocytes and is essential for the formation of antibodies, which are vital for humoral immunity. Structurally, IGLC2 consists of 151 amino acids and has a theoretical weight of approximately 16.02 kDa, facilitating its function in immune defense mechanisms. IGLC2 has been associated with various diseases, notably Autism Spectrum Disorder and triple-negative breast cancer (TNBC), where its expression levels correlate with patient prognosis and response to immunotherapy.
| 规格 | 起售价 |
|---|---|
| 登录后可查看 | |
技术参数
- 靶点基因名
- IGLC2
- 蛋白别名
- immunoglobulin lambda constant 2; IGLC2
- UniProt
- P0DOY2
- 物种
- Human
产品详情
- 靶点名称
- IGLC2
- 蛋白名称
- immunoglobulin lambda constant 2
- 蛋白别名
- Immunoglobulin lambda constant 2; Ig lambda chain C region Kern; Ig lambda chain C region NIG-64; Ig lambda chain C region SH; Ig lambda chain C region X; Ig lambda-2 chain C region
- 靶点基因名
- IGLC2
- UniProt
- P0DOY2
- 来源物种
- Homo sapiens (Human)
- 物种反应性
- Human
背景介绍
Immunoglobulin lambda constant 2 (IGLC2) plays a crucial role in the immune response by enabling antigen binding and receptor interaction. This protein is primarily expressed by B lymphocytes and is essential for the formation of antibodies, which are vital for humoral immunity. Structurally, IGLC2 consists of 151 amino acids and has a theoretical weight of approximately 16.02 kDa, facilitating its function in immune defense mechanisms. IGLC2 has been associated with various diseases, notably Autism Spectrum Disorder and triple-negative breast cancer (TNBC), where its expression levels correlate with patient prognosis and response to immunotherapy.